A controlled trial of ambroxol in chronic bronchitis
- PMID: 3308343
- DOI: 10.1378/chest.92.4.618
A controlled trial of ambroxol in chronic bronchitis
Abstract
Ambroxol is a mucolytic agent which is widely used in chronic bronchitis in Europe. We conducted a double-blind randomized controlled trial of ambroxol vs matched placebo in 90 patients with chronic bronchitis and difficulty clearing secretions. It was concluded that there was no advantage to taking ambroxol.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
